One year’s experience of large-scale SARS-CoV-2 testing: Role and outcome from the Research Luxembourg COVID-19 task force

With over 59,000 cases of infection and 725 deaths, the COVID-19 pandemic represents a heavy healthcare burden in Luxembourg, as it does across the world. A total of 626,108 people are living in Luxembourg and more than 200,000 frontier workers cross the French, Belgian, and German borders every day.

The Luxembourg government has set-up a large-scale testing strategy that is structured, targeted, and flexible with the aim of testing representative samples of the population where COVID-19 PCR tests are offered to residents and cross-border workers.

To support this initiative, the COVID-19 Task Force has been set-up to offer the health system the combined expertise available within the Luxembourg public research sector.

This webinar will focus on large-scale testing and will describe the COVID-19 activities including evaluation and implementation of diagnostic methods in virology and immunology, epidemiological studies, as well as research and development activities.

Learning objectives:

• Learn about the large-scale COVID-19 PCR testing program set up by the government of Luxembourg, including enrollment, sampling, and testing methods.
• Understand how the COVID-19 task force combined expertise to support the health system and research efforts.
• Learn about the benefits of such a program in terms of public health as well as research outcomes.

Who should attend?

• Laboratory Directors, Laboratory Managers

CEU credits & certificate of attendance

Attendees of this webinar are entitled to P.A.C.E. credits from the ASCLS and/or ACCENT credits from the AACC.